7Baggers
 Insider Sell: Sanjay Singh Sells Shares of MannKind Corp (MNKD)  GuruFocus Sat, 15 Nov 2025 02:05:29 GMT
 mannkind evp singh sells $94k in stock by investing.com  Investing.com South Africa Sat, 15 Nov 2025 01:34:39 GMT
 Mannkind EVP Singh sells $94k in stock  Investing.com Sat, 15 Nov 2025 01:34:01 GMT
 MannKind (NASDAQ:MNKD) Now Covered by Leerink Partners  MarketBeat Fri, 14 Nov 2025 17:39:53 GMT
 Wedbush Forecasts MannKind's FY2025 Earnings (NASDAQ:MNKD)  MarketBeat Thu, 13 Nov 2025 12:57:19 GMT
 here's why we think mannkind (nasdaq:mnkd) is well worth watching  富途牛牛 Wed, 12 Nov 2025 12:40:27 GMT
 mannkind halts phase 3 trial for mnkd-101  MSN Wed, 12 Nov 2025 02:07:22 GMT
 MannKind to Present at the Jefferies Global Healthcare Conference  GlobeNewswire Tue, 11 Nov 2025 21:05:00 GMT
 MannKind (NASDAQ:MNKD) Shares Gap Down - Here's What Happened  MarketBeat Tue, 11 Nov 2025 19:38:46 GMT
 rbc capital adjusts mnkd price target, maintains outperform rati  GuruFocus Tue, 11 Nov 2025 16:47:02 GMT
 Wells Fargo Lowers Price Target for MannKind (MNKD) Amid Overwei  GuruFocus Tue, 11 Nov 2025 16:12:27 GMT
 mannkind price target lowered to $10 from $15 at oppenheimer  TipRanks Tue, 11 Nov 2025 13:13:16 GMT
 mannkind halts phase 3 trial of nebulized ntm lung disease treatment  Investing.com Nigeria Tue, 11 Nov 2025 06:54:50 GMT
 mannkind stock price target lowered to $7.50 at rbc on ntm trial failure  Investing.com Nigeria Tue, 11 Nov 2025 00:08:51 GMT
 transcript : mannkind corporation - special call  MarketScreener Mon, 10 Nov 2025 18:05:32 GMT
 danbury biopharma firm halts late-stage drug trial after disappointing results  Hartford Business Journal Mon, 10 Nov 2025 17:02:39 GMT
 mannkind corp. hits day high with strong 10.58% intraday surge  Markets Mojo Mon, 10 Nov 2025 16:37:05 GMT
 mannkind (mnkd) halts phase 3 trial due to ineffectiveness  GuruFocus Mon, 10 Nov 2025 16:35:21 GMT
 mannkind (mnkd) halts mnkd-101 trial, stock falls 10%  GuruFocus Mon, 10 Nov 2025 16:09:18 GMT
 mannkind (mnkd) halts phase 3 trial for lung disease treatment  GuruFocus Mon, 10 Nov 2025 14:12:46 GMT
 MannKind discontinues Phase 3 trial for MNKD-101 in NTM lung disease  Investing.com Mon, 10 Nov 2025 13:43:18 GMT
 mannkind halts phase 3 trial for mnkd-101  TipRanks Mon, 10 Nov 2025 13:30:46 GMT
 mannkind halts phase 3 trial of nebulized ntm lung disease treatment  Investing.com Mon, 10 Nov 2025 13:26:00 GMT
 cantor fitzgerald forecasts lower earnings for mannkind  MarketBeat Sat, 08 Nov 2025 08:00:00 GMT
 mannkind (nasdaq:mnkd) announces quarterly earnings results  MarketBeat Thu, 06 Nov 2025 20:39:42 GMT
 mannkind corporation (nasdaq:mnkd) q3 2025 earnings call transcript  Insider Monkey Thu, 06 Nov 2025 14:23:26 GMT
 mannkind q3 2025 slides: record revenue of $82m fueled by tyvaso dpi and furoscix  Investing.com Nigeria Thu, 06 Nov 2025 10:40:24 GMT
 mannkind corporation reports strong q3 2025 growth  TipRanks Thu, 06 Nov 2025 08:37:30 GMT
 decoding mannkind corp (mnkd): a strategic swot insight  GuruFocus Thu, 06 Nov 2025 05:26:15 GMT
 mannkind (mnkd) reports q3 earnings: what key metrics have to say  sharewise.com Thu, 06 Nov 2025 02:05:53 GMT
 mannkind (mnkd) tops q3 earnings and revenue estimates  sharewise.com Thu, 06 Nov 2025 01:57:03 GMT
 mannkind’s record q3 2025 earnings and strategic moves  TipRanks Thu, 06 Nov 2025 01:37:42 GMT
 mannkind q3 2025 earnings call transcript  MarketBeat Wed, 05 Nov 2025 23:28:54 GMT
 mannkind (mnkd) surpasses q3 earnings expectations, stock rises  GuruFocus Wed, 05 Nov 2025 20:18:43 GMT
 mannkind earnings jump as revenue grows and wall street cheers  Finimize Wed, 05 Nov 2025 17:32:24 GMT
 mannkind : earnings presentation (bd9d29)  MarketScreener Wed, 05 Nov 2025 14:26:12 GMT
 mannkind earnings beat by $0.05, revenue topped estimates  Investing.com Wed, 05 Nov 2025 14:08:46 GMT

MannKind Corporation
(NASDAQ:MNKD) 

MNKD stock logo

MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. The company offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It...

Founded: 1991
Full Time Employees: 232
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends